IP News Federal Circuit Reinstates $177M Teva Verdict Against Eli Lilly in Migraine Drug Patent Dispute
The U.S. Court of Appeals for the Federal Circuit on April 16, 2026 reinstated a $177 million jury verdict in favor of T...
2026.04.18
IP News